Connor Clark & Lunn Investment Management Ltd. Takes Position in Syneos Health, Inc. (NASDAQ:SYNH)

Connor Clark & Lunn Investment Management Ltd. purchased a new stake in shares of Syneos Health, Inc. (NASDAQ:SYNHGet Rating) during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor purchased 9,501 shares of the company’s stock, valued at approximately $681,000.

Several other hedge funds and other institutional investors have also recently modified their holdings of the company. State of Alaska Department of Revenue lifted its holdings in shares of Syneos Health by 1.0% during the 2nd quarter. State of Alaska Department of Revenue now owns 14,732 shares of the company’s stock valued at $1,055,000 after buying an additional 140 shares during the period. Exchange Traded Concepts LLC raised its holdings in Syneos Health by 2.3% in the 2nd quarter. Exchange Traded Concepts LLC now owns 6,702 shares of the company’s stock worth $480,000 after purchasing an additional 152 shares during the period. Arizona State Retirement System raised its holdings in Syneos Health by 0.6% in the 1st quarter. Arizona State Retirement System now owns 28,030 shares of the company’s stock worth $2,269,000 after purchasing an additional 178 shares during the period. Harbor Investment Advisory LLC raised its holdings in Syneos Health by 13.4% in the 2nd quarter. Harbor Investment Advisory LLC now owns 1,664 shares of the company’s stock worth $119,000 after purchasing an additional 197 shares during the period. Finally, CWM LLC raised its holdings in Syneos Health by 124.7% in the 2nd quarter. CWM LLC now owns 418 shares of the company’s stock worth $30,000 after purchasing an additional 232 shares during the period. 94.80% of the stock is owned by institutional investors.

Syneos Health Stock Up 0.4 %

Shares of NASDAQ SYNH opened at $29.84 on Thursday. The company has a debt-to-equity ratio of 0.84, a current ratio of 1.14 and a quick ratio of 1.10. The company has a market cap of $3.07 billion, a P/E ratio of 10.85 and a beta of 1.75. Syneos Health, Inc. has a 1 year low of $22.89 and a 1 year high of $104.18. The firm has a 50-day simple moving average of $49.21 and a two-hundred day simple moving average of $62.95.

Wall Street Analysts Forecast Growth

A number of equities analysts recently commented on SYNH shares. Mizuho decreased their target price on Syneos Health from $87.00 to $66.00 and set a “buy” rating on the stock in a report on Wednesday, October 12th. UBS Group started coverage on Syneos Health in a report on Wednesday, September 7th. They issued a “neutral” rating and a $68.00 target price on the stock. StockNews.com started coverage on Syneos Health in a report on Wednesday, October 12th. They issued a “hold” rating on the stock. Guggenheim cut Syneos Health from a “buy” rating to a “neutral” rating in a report on Wednesday, September 14th. Finally, JPMorgan Chase & Co. lowered Syneos Health from an “overweight” rating to a “neutral” rating and cut their price target for the stock from $85.00 to $53.00 in a research note on Tuesday, October 18th. Seven research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. Based on data from MarketBeat, Syneos Health presently has a consensus rating of “Hold” and an average target price of $56.90.

Syneos Health Profile

(Get Rating)

Syneos Health, Inc provides biopharmaceutical outsourcing solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, devices, and digital therapeutics in the Phase I to IV of clinical development.

Further Reading

Institutional Ownership by Quarter for Syneos Health (NASDAQ:SYNH)

Receive News & Ratings for Syneos Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Syneos Health and related companies with MarketBeat.com's FREE daily email newsletter.